Intravesical oncolytic viral therapy using attenuated, replication-competent herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model.

The FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Volumn 15, Issue 7, 2001, Pages 1306-1308

  Cozzi, P J ^a   Malhotra, S ^a   McAuliffe, P ^a   Kooby, D A ^a   Federoff, H J ^a   Huryk, B ^a   Johnson, P ^a   Scardino, P T ^a   Heston, W D ^a   Fong, Y ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTICLE; BIOLOGICAL THERAPY; BLADDER TUMOR; CELL CULTURE; DISEASE MODEL; GENETICS; HERPES SIMPLEX VIRUS; HUMAN; METHODOLOGY; MOUSE; PATHOGENICITY; PHYSIOLOGY; VIROLOGY; VIRUS REPLICATION;

ANIMALS; BIOLOGICAL THERAPY; DISEASE MODELS, ANIMAL; HUMANS; MICE; SIMPLEXVIRUS; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS; VIRUS REPLICATION;

EID: 0035349907     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.00-0533fje     Document Type: Article

References (0)